|
The Immunohistochemistry Antibody Company
|
|
|
General Cancer Screen 65 Tissue Microarray - LS-SCA65This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SCA65 |
| Product Name: | General Cancer Screen 65 |
| Description: | Male genitourinary system inflammatory disease and cancer with stage/grade |
| Format: | FFPE |
| Category: | Human Multi-Tumor and Normal |
| QA/QC: | H&E reviewed |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 1 mm |
| Core Thickness: | 5 µm |
| Cases: | 80 |
| Cores: | 80 |
| Slides Per Set: | 1 |
LS-SCA65 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Bladder (Bla); Bladder, Mucosa (Bla); Bladder, Myofibroblast (Bla); Kidney (Kid); Penis (Pen); Penis, Skin (Pen); Prostate (Pst); Skin, Penis (Skn); Testis (Tes); Ureter (Urt); Ureter, Epithelium (Urt); Ureter, Transitional epithelium (Urt); Urethra (Ure);
LS-SCA65 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Grade | Tumor Stage |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 38 y | Kidney (Kid) | Normal | Benign non-neoplastic | |||
| 1 | A2 | Human | M | 40 y | Kidney (Kid) | Normal | Benign non-neoplastic | |||
| 1 | A3 | Human | M | 48 y | Kidney (Kid) | Normal | Benign non-neoplastic | |||
| 1 | A4 | Human | M | 47 y | Kidney (Kid) | Normal | Benign non-neoplastic | |||
| 1 | A5 | Human | M | 52 y | Kidney (Kid) | Pyelonephritis, Chronic | Inflammatory | |||
| 1 | A6 | Human | M | 65 y | Kidney (Kid) | Pyelonephritis, Chronic | Inflammatory | |||
| 1 | A7 | Human | M | 42 y | Kidney (Kid) | Interstitial nephritis | Inflammatory | |||
| 1 | A8 | Human | M | 56 y | Kidney (Kid) | Diffuse sclerosing glomerulonephritis | Diseased | |||
| 1 | A9 | Human | M | 37 y | Kidney (Kid) | Tuberculosis, Renal | Diseased | |||
| 1 | A10 | Human | M | 42 y | Kidney (Kid) | Tuberculosis, Renal | Diseased | |||
| 1 | B1 | Human | M | 43 y | Kidney (Kid) | Tuberculosis, Renal | Diseased | |||
| 1 | B2 | Human | M | 2 y | Kidney (Kid) | Inflammation, Chronic with with glomerular atrophy | Inflammatory | |||
| 1 | B3 | Human | M | 59 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 1 | I |
| 1 | B4 | Human | M | 72 y | Kidney (Kid) | Transitional cell carcinoma | Malignant | T1N0M0 | 3 | I |
| 1 | B5 | Human | M | 50 y | Kidney (Kid) | Papillary renal cell carcinoma | Malignant | T1N0M0 | I | |
| 1 | B6 | Human | M | 36 y | Kidney (Kid) | Papillary renal cell carcinoma | Malignant | T1N0M0 | I | |
| 1 | B7 | Human | M | 48 y | Prostate (Pst) | Normal | Benign non-neoplastic | |||
| 1 | B8 | Human | M | 43 y | Prostate (Pst) | Normal | Benign non-neoplastic | |||
| 1 | B9 | Human | M | 28 y | Prostate (Pst) | Normal | Benign non-neoplastic | |||
| 1 | B10 | Human | M | 45 y | Prostate (Pst) | Normal | Benign non-neoplastic | |||
| 1 | C1 | Human | M | 27 y | Prostate (Pst) | Inflammation, Chronic | Inflammatory | |||
| 1 | C2 | Human | M | 68 y | Prostate (Pst) | Inflammation, Chronic | Inflammatory | |||
| 1 | C3 | Human | M | 69 y | Prostate (Pst) | Inflammation, Chronic | Inflammatory | |||
| 1 | C4 | Human | M | 71 y | Prostate (Pst) | Inflammation, Chronic with with gland ectasia | Inflammatory | |||
| 1 | C5 | Human | M | 62 y | Prostate (Pst) | Hyperplasia | Diseased | |||
| 1 | C6 | Human | M | 66 y | Prostate (Pst) | Hyperplasia | Diseased | |||
| 1 | C7 | Human | M | 64 y | Prostate (Pst) | Hyperplasia | Diseased | |||
| 1 | C8 | Human | M | 61 y | Prostate (Pst) | Hyperplasia with intraepithelial neoplasia | Diseased | 1 | ||
| 1 | C9 | Human | M | 75 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N1M1c | 1 | IV |
| 1 | C10 | Human | M | 58 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M0 | 2 | II |
| 1 | D1 | Human | M | 80 y | Prostate (Pst) | Adenocarcinoma | Malignant | T4N1M1c | 2 | IV |
| 1 | D2 | Human | M | 69 y | Prostate (Pst) | Adenocarcinoma | Malignant | T3N0M0 | 2 | III |
| 1 | D3 | Human | M | 35 y | Bladder (Bla) | Normal | Benign non-neoplastic | |||
| 1 | D4 | Human | M | 50 y | Bladder (Bla) | Normal | Benign non-neoplastic | |||
| 1 | D5 | Human | M | 22 y | Bladder (Bla) | Normal | Benign non-neoplastic | |||
| 1 | D6 | Human | M | 61 y | Bladder, Mucosa (Bla) | Inflammation, Chronic | Inflammatory | |||
| 1 | D7 | Human | M | 63 y | Bladder (Bla) | Cystitis glandularis | Inflammatory | |||
| 1 | D8 | Human | M | 36 y | Bladder (Bla) | Cystitis glandularis | Inflammatory | |||
| 1 | D9 | Human | M | 17 y | Bladder, Myofibroblast (Bla) | Hyperplasia | Diseased | |||
| 1 | D10 | Human | M | 75 y | Bladder (Bla) | Inverted papilloma | Tumor | |||
| 1 | E1 | Human | M | 60 y | Bladder (Bla) | Paraganglioma | Tumor | |||
| 1 | E2 | Human | M | 35 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 1 | II |
| 1 | E3 | Human | M | 41 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 2 | I |
| 1 | E4 | Human | M | 55 y | Bladder (Bla) | Transitional cell carcinoma with squamous metaplasia | Malignant | T3bN0M0 | 3 | III |
| 1 | E5 | Human | M | 16 y | Ureter (Urt) | Normal | Benign non-neoplastic | |||
| 1 | E6 | Human | M | 45 y | Ureter (Urt) | Normal | Benign non-neoplastic | |||
| 1 | E7 | Human | M | 47 y | Ureter (Urt) | Normal | Benign non-neoplastic | |||
| 1 | E8 | Human | M | 68 y | Ureter (Urt) | Inflammation, Chronic | Inflammatory | |||
| 1 | E9 | Human | M | 76 y | Ureter, Epithelium (Urt) | Inflammation, Chronic with hyperplasia | Inflammatory | |||
| 1 | E10 | Human | M | 85 y | Ureter (Urt) | Inflammation, Chronic | Inflammatory | |||
| 1 | F1 | Human | M | 50 y | Ureter (Urt) | Polyp, Fibroepithelial | Tumor | |||
| 1 | F2 | Human | M | 53 y | Ureter, Transitional epithelium (Urt) | Hyperplasia, Atypical | Diseased | |||
| 1 | F3 | Human | M | 56 y | Ureter, Epithelium (Urt) | Hyperplasia, Atypical | Diseased | |||
| 1 | F4 | Human | M | 57 y | Ureter (Urt) | Transitional cell carcinoma | Malignant | T2N0M0 | 1 | II |
| 1 | F5 | Human | M | 82 y | Ureter (Urt) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II |
| 1 | F6 | Human | M | 80 y | Urethra (Ure) | Squamous cell carcinoma | Malignant | T3N0M0 | 2 | III |
| 1 | F7 | Human | M | 30 y | Testis (Tes) | Normal | Benign non-neoplastic | |||
| 1 | F8 | Human | M | 45 y | Testis (Tes) | Normal | Benign non-neoplastic | |||
| 1 | F9 | Human | M | 45 y | Testis (Tes) | Normal | Benign non-neoplastic | |||
| 1 | F10 | Human | M | 68 y | Testis (Tes) | Tuberculosis | Diseased | |||
| 1 | G1 | Human | M | 27 y | Testis (Tes) | Tuberculosis | Diseased | |||
| 1 | G2 | Human | M | 31 y | Testis (Tes) | Tuberculosis | Diseased | |||
| 1 | G3 | Human | M | 44 y | Testis (Tes) | Eosinophilic granuloma | Tumor | |||
| 1 | G4 | Human | M | 70 y | Testis (Tes) | Atrophy | Diseased | |||
| 1 | G5 | Human | M | 39 y | Testis (Tes) | Cryptorchidism | Diseased | |||
| 1 | G6 | Human | M | 59 y | Testis (Tes) | Seminoma | Tumor | T4N0M0 | I | |
| 1 | G7 | Human | M | 52 y | Testis (Tes) | Seminoma with necrosis | Tumor | T2N0M0 | I | |
| 1 | G8 | Human | M | 38 y | Testis (Tes) | Seminoma | Tumor | T1N0M0 | I | |
| 1 | G9 | Human | M | 45 y | Skin, Penis (Skn) | Normal | Benign non-neoplastic | |||
| 1 | G10 | Human | M | 35 y | Skin, Penis (Skn) | Normal | Benign non-neoplastic | |||
| 1 | H1 | Human | M | 76 y | Skin, Penis (Skn) | Normal | Benign non-neoplastic | |||
| 1 | H2 | Human | M | 46 y | Penis, Skin (Pen) | Inflammation, Chronic | Inflammatory | |||
| 1 | H3 | Human | M | 73 y | Penis, Skin (Pen) | Inflammation, Chronic | Inflammatory | |||
| 1 | H4 | Human | M | 46 y | Penis, Skin (Pen) | Inflammation, Chronic | Inflammatory | |||
| 1 | H5 | Human | M | 42 y | Penis (Pen) | Syphilis, First stage | Diseased | |||
| 1 | H6 | Human | M | 51 y | Penis (Pen) | Syphilis, First stage | Diseased | |||
| 1 | H7 | Human | M | 26 y | Penis (Pen) | Condyloma acuminatum | Diseased | |||
| 1 | H8 | Human | M | 54 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T2N0M0 | 1 | II |
| 1 | H9 | Human | M | 73 y | Penis (Pen) | Squamous cell carcinoma | Malignant | T2N0M0 | 1-2 | II |
| 1 | H10 | Human | M | 60 y | Penis (Pen) | Verrucous carcinoma | Malignant | TaN0M0 | 1 |